Aurinia Pharmaceuticals
AUPH
#5245
Rank
C$1.52 B
Marketcap
$11.10
Share price
-2.98%
Change (1 day)
61.05%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): C$16.8 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.23 Billion. , an increase over its 2023 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 C$17.46 M-116.44%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.26 Billion61.9%
2020 -C$0.16 Billion-9.73%
2019 -C$0.18 Billion92.65%
2018 -C$91.26 Million36.39%
2017 -C$66.91 Million106.29%
2016 -C$32.44 Million-15.4%
2015 -C$38.34 Million65.84%
2014 -C$23.12 Million129.82%
2013 -C$10.06 Million-26.6%
2012 -C$13.71 Million
2010 -C$7.76 Million-39.22%
2009 -C$12.77 Million-43.78%
2008 -C$22.71 Million-53.19%
2007 -C$48.51 Million42.97%
2006 -C$33.94 Million-23.03%
2005 -C$44.09 Million36.1%
2004 -C$32.4 Million172.57%
2003 -C$11.89 Million484.61%
2002 -C$2.04 Million
2000 -C$9.66 Million453.81%
1999 -C$1.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$6.79 B 38,814.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$7.8 Million-144.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$31.45 Million-280.09%๐Ÿ‡บ๐Ÿ‡ธ USA